Supernus Announces Third Quarter 2018 Financial Results and Record Quarterly Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Supernus Pharma (SUPN) Tops Q3 EPS by 11c; Lowers FY Revenue Outlook
November 6, 2018 4:22 PM ESTSupernus Pharma (NASDAQ: SUPN) reported Q3 EPS of $0.52, $0.11 better than the analyst estimate of $0.41. Revenue for the quarter came in at $103 million versus the consensus estimate of $100.61 million.
GUIDANCE:
Supernus Pharma sees FY2018 revenue of $388-395 million, versus prior... More
